Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Nanotechnology In The Popular News For Skin Treatments, Gene Regulation And Sirna Methods

    The popular news webpage msnbc.com is featuring an article in their health section on bio nanotechnology with headline, "Gene healing in a lotion? Researchers say they're close."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Nanotechnology: Who Will Be The Leaders In The Fifth Technology Revolution?

    Modern history can be broken into several periods of technological revolutions that developed in different regions throughout the world.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    Nanovember Programs Highlight Increasing Role Of Nanotechnology Thanks To University Of Albany’s College Of Nanoscale Science And Engineering

    NANOvember is coming thanks to SUNY Albany’s College of Nanoscale Science and Engineering (CNSE).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    NIOSH Determines That Inhaled Nanoscale Titanium Dioxide Is A Potential Occupational Carcinogen; Establishes Recommended Exposure Limits

    According to this report, the National Institute for Occupational Safety and Health ("NIOSH") has determined that inhalation of nanoscale form titanium dioxide (TiO2) is a potential occupational carcinogen, and has recommended new occupational exposure limits for the material.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    NORD Annual Breakthrough Summit

    In October, NORD will also hold its annual Breakthrough Summit in Washington, DC on October 20-22, 2024. This event draws over 1,000 attendees including patients/caregivers...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    NSCEB Roadshow Highlights Biotechnology Across America

    The National Security Commission on Emerging Biotechnology (NSCEB) is holding a roadshow to ...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bergeson & Campbell
    Bergeson & Campbell
  • Article

    Observers Disagree About Whether Report Of Tainted Thyroid Supplements Points To Wider Problems In Market

    Jason Sapsin was quoted in the NutraIngredients-USA article, "Observers Disagree About Whether Report of Tainted Thyroid Supplements Points to Wider Problems in Market".
    United StatesFood, Drugs, Healthcare, Life Sciences
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    OCR Releases Ebola Bulletin

    The recent Ebola outbreak has prompted the US Department of Health and Human Services, Office for Civil Rights ("OCR"), the agency responsible for enforcing the Health Insurance Portability and Accountability Act ("HIPAA"), to release a new bulletin for covered entities and business associates regarding their privacy obligations in emergency situations.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    OCR Releases HIPAA Guide For Law Enforcement

    The Office for Civil Rights of the U.S. Department of Health & Human Services announced the addition of a new resource on its website to assist law enforcement and emergency planners.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Part IV: When National Security Meets Life Sciences: Navigating The Expanding U.S. And European Regulatory Landscapes

    National security considerations are rapidly reshaping the life sciences industry, with evolving U.S. and European regulations affecting research, clinical trials, supply chains, investment, data governance, and commercialization. This webinar examines the latest developments across the U.S. and European national security landscape, including countries of concern, investment controls, human 'omic data restrictions, and AI-related risks.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Phacilitate Leaders/World Stem Cell Summit - Regenerative Medicine Enforcement Developments For Clinicians

    Barbara Binzak Blumenfeld presented at the Phacilitate Leaders/World Stem Cell Summit conference on January 22 in Miami. Her presentation, "Regenerative Medicine Enforcement...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    PhRMA Criticizes FDA's Social Media Guidance

    Drug makers are responding with heavy criticism to FDA's draft guidance on interactive promotional media for drugs and biologics.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Polpharma And Tuteur Enter License For The Commercialization Of A Biosimilar Targeting Autoimmune Diseases In Latin America

    Explore the latest developments in biosimilar approvals, regulatory updates, and strategic acquisitions shaping the pharmaceutical landscape.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Preparing A Promising Drug Candidate For ANDA Litigation - Part 2

    If you read part one of this series, you appreciate that it is imperative that all individuals involved in drug development — including scientific, regulatory, marketing, and financial personnel...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    President Obama Signs Executive Order On Combating Antibiotic-Resistant Bacteria

    President Obama issued a national strategy to spur action within the federal government to address the public health challenge of antibiotic-resistant bacteria.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    President Obama Signs Executive Order On Combating Antibiotic-Resistant Bacteria October 2014

    President Obama issued a national strategy to spur action within the federal government to address the public health challenge of antibiotic-resistant bacteria.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    President Signs Drug Quality And Security Act

    On November 27, 2013, President Obama signed the Drug Quality and Security Act, which amends the Food, Drug and Cosmetic Act. The
    United StatesFood, Drugs, Healthcare, Life Sciences
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    Protecting Children From Chemical And Surgical Mutilation (Trump EO Tracker)

    The Executive Order announces that the United States "will not fund, sponsor, promote, assist, or support the so-called ‘transition' of a child from one sex to another and will rigorously enforce all laws...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Akin
    Akin
  • Article

    Redefining Early Stage Investments (RESI) On Mars Conference

    On April 10, 2018, Partner Stephen Goodman, Co-Chair of Pryor Cashman's Life Sciences Group, will moderate a panel at the Redefining Early Stage Investments ...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Pryor Cashman LLP
    Pryor Cashman LLP
  • Article

    Results From Early PTAB Decisions On Inter Partes Review Petitions

    Based on a review of early results of PTAB's decisions on inter partes reviews, IP Litigation Partner and Chair of Foley's Patent Office Trials Practice Matthew A. Smith has authored a short article providing summary statistics and observations on the characteristics of successful petitions.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Showing 161–180 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics